- Home
- GGB vs PCVX Comparison
GGB vs PCVX Comparison
Compare GGB & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GGB | PCVX |
|---|---|---|
| Founded | 1901 | 2013 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 6.1B |
| IPO Year | 1999 | 2020 |
Fundamental Metrics
Financial Performance| Metric | GGB | PCVX |
|---|---|---|
| Price | $4.35 | $54.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | $4.60 | ★ $97.67 |
| AVG Volume (30 Days) | ★ 23.1M | 1.6M |
| Earning Date | 02-23-2026 | 02-24-2026 |
| Dividend Yield | ★ 2.40% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.28 | N/A |
| Revenue | ★ $13,079,666,170.00 | N/A |
| Revenue This Year | $6.59 | N/A |
| Revenue Next Year | $2.59 | N/A |
| P/E Ratio | $14.19 | ★ N/A |
| Revenue Growth | ★ 7.37 | N/A |
| 52 Week Low | $2.27 | $27.66 |
| 52 Week High | $4.66 | $87.42 |
Technical Indicators
Market Signals| Indicator | GGB | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 58.39 | 58.89 |
| Support Level | $4.22 | $53.12 |
| Resistance Level | $4.30 | $58.00 |
| Average True Range (ATR) | 0.13 | 3.35 |
| MACD | -0.03 | -0.04 |
| Stochastic Oscillator | 42.44 | 52.19 |
Price Performance
Historical ComparisonAbout GGB Gerdau S.A.
Gerdau SA produces steel and steel products. The company operates in civil construction, agriculture, automotive, iron ore, exports, research and development, and home steel products sectors. It offers products such as nails, rebar, columns, billets, slabs, tribar tutors, mechanical construction bars, and reinforced steel locks. The company's geographical segment includes Brazil Operations; North America Operations; South America Operations as well as Special Steel Operations. It derives the majority of its revenue from the Brazil Operations segment.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.